Active Ingredient History
Gluconic acid is a natural compound produced from glucose through a simple dehydrogenation reaction catalysed by glucose oxidase. Gluconic acid and its salts are used in the formulation of food, pharmaceutical and hygienic products. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Anaplasia (Phase 1)
Asthenozoospermia (Phase 2)
Atrophic Vaginitis (Phase 3)
Bacterial Infections (Phase 2/Phase 3)
Bone Marrow Transplantation (Phase 2/Phase 3)
Botulinum Toxins (Early Phase 1)
Brain Neoplasms (Phase 2)
Bronchiolitis (Phase 3)
Canavan Disease (Phase 2)
Carcinoma, Verrucous (Phase 2)
Cardiomyopathies (Phase 1)
Cataract (Phase 2)
Cholera (Phase 1/Phase 2)
Chronic Periodontitis (Phase 3)
Colorectal Surgery (Phase 4)
Conjunctivitis, Bacterial (Phase 4)
Cough (Phase 2)
COVID-19 (Phase 3)
Critical Illness (Phase 1/Phase 2)
Death (Phase 3)
Deficiency Diseases (Phase 2)
Dehydration (Phase 2/Phase 3)
Dermatitis (Phase 3)
Dermatology (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Diabetic Retinopathy (Phase 2)
Diarrhea (Phase 4)
Dysgeusia (Phase 3)
Eczema (Phase 2)
Enzymes (Phase 2)
Epiretinal Membrane (Phase 4)
Esophageal Neoplasms (Phase 2)
Facial Neuralgia (Early Phase 1)
Feeding and Eating Disorders (Phase 4)
Gastroenteritis (Phase 4)
Glaucoma (Phase 2/Phase 3)
Glaucoma, Neovascular (Phase 2)
Glaucoma, Open-Angle (Phase 2)
Graves Ophthalmopathy (Phase 2/Phase 3)
Head and Neck Neoplasms (Phase 3)
Heart Failure (Phase 1)
Hematopoietic Stem Cell Transplantation (Phase 2)
Hemorrhoids (Phase 3)
Hepatitis, Alcoholic (Phase 2/Phase 3)
Hepatitis C (Phase 3)
Hepatolenticular Degeneration (Phase 4)
HIV Infections (Phase 4)
Hypovolemia (Phase 4)
Infant (Phase 2)
Inflammation (Phase 4)
Inositol (Phase 4)
Insulin Resistance (Phase 4)
Intertrigo (Early Phase 1)
Jaundice, Neonatal (Phase 1/Phase 2)
Kidney Failure, Chronic (Phase 2)
Kidney Neoplasms (Phase 2)
Leukemia (Phase 2)
Liver Neoplasms (Phase 2)
Lung Neoplasms (Phase 2)
Malaria (Phase 2/Phase 3)
Melanoma (Phase 2)
Melanosis (Phase 4)
Meningitis (Phase 3)
Mucositis (Phase 2/Phase 3)
Nerve Sheath Neoplasms (Phase 2)
Obesity (Phase 2/Phase 3)
Only Child (Phase 1)
Oral Submucous Fibrosis (Phase 3)
Pancreatic Neoplasms (Phase 4)
Pediatric Obesity (Phase 4)
Pharmacology (Phase 2)
Plasma (Phase 4)
Pneumonia (Phase 3)
Respiratory Tract Infections (Phase 4)
Sepsis (Phase 3)
Stomach Neoplasms (Phase 2)
Stomatitis, Aphthous (Phase 2)
Sun Protection Factor (Phase 3)
Teratoma (Phase 3)
Tinnitus (Phase 2)
Tissue Adhesions (Phase 2)
Tobacco Use Disorder (Phase 2)
Tuberculosis, Pulmonary (Phase 3)
Tumor Suppressor Protein p53 (Phase 2)
Typhoid Fever (Phase 1/Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Warts (Phase 3)
Zinc (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
